Health · Medical Research · 2 hrs ago
Enzyme supplement may ease IBS symptoms, study suggests
A study found that an oral enzyme supplement appeared to reduce IBS symptom severity in adults.
The study included more than 400 patients taking an enzyme blend designed to target FODMAPs.
IBS, or irritable bowel syndrome, is the condition studied, and FODMAPs are short for fermentable carbohydrates.
The research was prospective and single-arm, meaning it followed participants but had no separate comparison group.
That means the findings suggest a possible benefit but do not establish that the supplement caused the improvement.
The information available does not say what happens next.
A prospective, single-arm study found that an oral enzyme supplement appeared to reduce symptom severity in adults with irritable bowel syndrome.
The enzyme blend was designed to target FODMAPs, or fermentable carbohydrates.
More than 400 patients took the supplement.
The source does not provide the size of the symptom reduction or further study details.
- Who
- Adults with irritable bowel syndrome took part in the study.
- What
- A prospective, single-arm study found that an oral enzyme supplement appeared to reduce symptom severity.
- When
- Not stated
- Where
- Not stated
- Why
- The enzyme blend was designed to target FODMAPs.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Study design
- Prospective, single-arm
- Participants
- More than 400 patients
- Condition
- Irritable bowel syndrome
- Supplement
- Oral enzyme blend targeting FODMAPs











